Earnings Feed
Start Free
NeuroBo Pharmaceuticals, Inc.·3

Jan 9, 9:28 PM ET

JK BioPharma Solutions, Inc 3

3 · NeuroBo Pharmaceuticals, Inc. · Filed Jan 9, 2020

Insider Transaction Report

Form 3
Period: 2019-12-30
NeuroBo Pharmaceuticals, Inc.NRBO
JK BioPharma Solutions, Inc
10% Owner
Holdings

  • Common Stock

    1,817,842

  • Common Stock

    800,170
Footnotes (2)
  • [F1]These shares are owned directly by JK BioPharma Solutions, Inc., a 10% owner of the Issuer, and indirectly by Dr. Sun Dae Kang, as director of JK BioPharma Solutions, Inc. Dr. Kang disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
  • [F2]These shares are owned directly by Dr. Sun Dae Kang.

Documents

2 files